Meningitis
4Curable or preventable in mostAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.
Milestones
dot size = significance- 1984Ceftriaxone approved (FDA)
- 2010Neisseria meningitidis oligosaccharide conjugated to corynebacterium diphtheriae crm197 approved (FDA)
- 1958Dexamethasone approved (FDA)
- 1964Amphotericin b approved (FDA)
- 1965Ampicillin approved (FDA)
- 1971Flucytosine approved (FDA)
- 1990Fluconazole approved (FDA)
- 1996Meropenem approved (FDA)
- 2012Neisseria meningitidis polysaccharide conjugated to tetanus toxoid approved (FDA)
- 2013Neisseria meningitidis outer membrane vesicles approved (FDA)
What's being tested now
Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.
See all 56 active Bacterial Meningitis trials on Clin2 →